A glucagon analog chemically stabilized for immediate treatment of life-threatening hypoglycemia

Molecular Metabolism

Volumn 3, Issue 3, 2014, Pages 293-300

  Chabenne, Joseph ^a   Chabenne, Maria DiMarchi ^a   Zhao, Yan ^a   Levy, Jay ^a   Smiley, David ^a   Gelfanov, Vasily ^a   DiMarchi, Richard ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Glucagon; Hypoglycemia; Insulin dependent diabetes; Peptide synthesis

Indexed keywords

ASPARAGINE; ASPARTIC ACID; CYCLIC AMP; GLUCAGON DERIVATIVE; GLUTAMINE; GLYCINE; HISTIDINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; BEAGLE; BIOLOGICAL ACTIVITY; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME STABILITY; ENZYME SYNTHESIS; GLUCOSE METABOLISM; HYPOGLYCEMIA; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STRUCTURE; REVIEW;

EID: 84897116097     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2014.01.006     Document Type: Article

References (28)

1. Unger R.H., Orci L. Physiology and pathophysiology of glucagon. Physiological Reviews 1976, 56(4):778-826.
2. Pohl S.L., Birnbaum L, Rodbell M. Glucagon-sensitive adenyl cylase in plasma membrane of hepatic parenchymal cells. Science 1969, 164(3879):566-567.
3. Gerich J.E., Langlois M., Noacco C., Karam J.H., Forsham P.H. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science. 182 1973, (108):171-173.
4. Lorenzi M., Bohannon N., Tsalikian E., Karam J.H. Duration of type I diabetes affects glucagon and glucose responses to insulin-induced hypoglycemia. Western Journal of Medicine 1984, 141(4):467-471.
5. Cryer P.E. Banting lecture. hypoglycemia: the limiting factor in the management of IDDM. Diabetes 1994, 43(11):1378-1389.
6. Shamoon H., et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes-mellitus. New England Journal of Medicine 1993, 329(14):977-986.
7. Gratzer W.B., Beaven G.H., Rattle H.W.E., Bradbury E.M. A conformational study of glucagon. European Journal of Biochemistry 1968, 3(3):276-283.
8. Joshi A.B., Rus E., Kirsch L.E. The degradation pathways of glucagon in acidic solutions. International Journal of Pharmaceutics 2000, 203(1-2):115-125.
9. Joshi A.B., Sawai M., Kearney W.M., Kirsch L.E. Studies on the mechanism of aspartic acid cleavage and glutamine deamidation in the acidic degradation of glucagon. Journal of Pharmaceutical Sciences 2005, 94(9):1912-1927.
10. Beaven G.H., Gratzer W.B., Davies H.G. Formation and structure of gels and fibrils from glucagon. European Journal of Biochemistry 1969, 11(1):37-42.
11. Gratzer W.B., E.Bailey E., Beaven G.H. Conformational states of glucagon. Biochemical and Biophysical Research Communications 1967, 28(6):914-919.
12. Onoue S., Ohshima K., Debari K., Koh K., Shioda S., Iwasa S., et al. Mishandling of the therapeutic peptide glucagon generates cytotoxic amyloidogenic fibrils. Pharmaceutical Research 2004, 21(7):1274-1283.
13. Chabenne J., DiMarchi M., Gelfanov V., DiMarchi R. Optimization of the native glucagon sequence for medicinal purposes. Journal of Diabetes Science and Technology 2010, 4(6):1322-1331.
14. Eng J., Kleinman W.A., Singh L., Singh G., Raufman J.P. Isolation and characterization of exendin-4, an exendin-3 analog, from heloderma-suspectum venom - further evidence for an exendin receptor on dispersed acini from guinea-pig pancreas. Journal of Biological Chemistry 1992, 267(11):7402-7405.
15. Neidigh J.W., Fesinmeyer R.M., Prickett K.S., Andersen N.H. Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states. Biochemistry 2001, 40(44):13188-13200.
16. Chen J., Yu L., Fang X., Li L., Li W. Stability of synthetic exendin-4 in human plasma in vitro. Protein and Peptide Letters 2007, 14(1):19-25.
17. Schnolzer M., Alewood P., Jones A., Alewood D., Kent S.B. In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences. International Journal of Peptide and Protein Research 1992, 40(3-4):180-193.
18. Fanelli C.G., Porcellati F., Rossetti P., Bolli G.B. Glucagon: the effects of its excess and deficiency on insulin action. Nutrition, Metabolism and Cardiovascular Diseases 2006, 16(Suppl. 1):S28-S34.
19. Joshi A.B., Kirsch L.E. The estimation of glutaminyl deamidation and aspartyl cleavage rates in glucagon. International Journal of Pharmaceutics 2004, 273(1-2):213-219.
20. Clarke S. Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins. International Journal of Peptide and Protein Research 1987, 30(6):808-821.
21. Geiger T., Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides - succinimide-linked reactions that contribute to protein-degradation. Journal of Biological Chemistry 1987, 262(2):785-794.
22. Toniolo C., Benedetti E. Structures of polypeptides from alpha-amino-acids disubstituted at the alpha-carbon. Macromolecules 1991, 24(14):4004-4009.
23. Kumita J.R., Weston C.J., Choo-Smith L.P., Woolley G.A., Smart O.S. Prevention of peptide fibril formation in an aqueous environment by mutation of a single residue to Aib. Biochemistry 2003, 42(15):4492-4498.
24. Chou P.Y., Fasman G.D. The conformation of glucagon: predictions and consequences. Biochemistry 1975, 14(11):2536-2541.
25. Karle I.L., Balaram P. Structural characteristics of alpha-helical peptide molecules containing Aib residues. Biochemistry 1990, 29(29):6747-6756.
26. Moretto V., Crisma M., Bonora G.M., Toniolo C., Balaram H., Balaram P. Comparison of the effect of 5 guest residues on the beta-sheet conformation of host (l-Val)N oligopeptides. Macromolecules 1989, 22(7):2939-2944.
27. Marshall G.R., Hodgkin E.E., Langs D.A., Smith G.D., Zabrocki J., Leplawy M.T. Factors governing helical preference of peptides containing multiple alpha,alpha-dialkyl amino-acids. Proceedings of the National Academy of Sciences of the United States of America 1990, 87(1):487-491.
28. Kumita J.R., Weston C.J., Choo-Smith L.P., Wooley G.A., Smart O.S. Prevention of peptide fibril formation in an aqueous environment by mutation of a single residue to Aib. Biochemistry 2003, 42(15):4492-4498.